| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9402355 | Journal of Surgical Research | 2005 | 7 Pages |
Abstract
After 8 weeks of arterial flow, decellularized vein allograft exhibits satisfactory strength, reduced antigenicity compared to fresh allograft, and supports cellular repopulation. These characteristics make it satisfactory for further tissue engineering; combined with luminal vascular cell seeding, it may prove useful as a small-diameter arterial bypass graft.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Niels D. M.D., Patrick J. M.D., Thomas N. Ph.D., Irving M. Ph.D., Christopher A. B.A., Timothy K. M.D., Eric S. M.D., Paul J. M.D.,